As of 30 Sep 2025, 2 institutional investors reported holding $21,131,000 in principal (par value) of CYTOKINETICS INC - NOTE 4.000%11/1.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $21,131,000 | $110,727,301 | 523.49% | 2 | |
| 2025 Q2 | $21,131,000 | $66,885,078 | 315.97% | 2 | |
| 2025 Q1 | $21,131,000 | $81,120,772 | 383.41% | 2 | |
| 2024 Q4 | $21,131,000 | $94,740,181 | 447.91% | 2 | |
| 2024 Q3 | $21,131,000 | $106,499,340 | 503.46% | 2 | |
| 2024 Q2 | $21,131,000 | $109,288,394 | 516.69% | 2 | |
| 2024 Q1 | $21,131,000 | $141,036,090 | 667.0% | 2 | |
| 2023 Q4 | $21,131,000 | $168,120,917 | +$3,104,063 | 795.75% | 2 |
| 2023 Q3 | $21,131,000 | $60,660,090 | 287.94% | 3 | |
| 2023 Q2 | $21,131,000 | $66,802,841 | 317.0% | 3 | |
| 2023 Q1 | $21,131,000 | $72,132,350 | +$7,988,406 | 340.9% | 3 |
| 2022 Q4 | $18,631,000 | $83,604,639 | 448.16% | 4 | |
| 2022 Q3 | $18,631,000 | $88,115,000 | -$20,687,000 | 472.33% | 4 |
| 2022 Q2 | $23,965,000 | $92,930,000 | -$407,718,489 | 387.81% | 6 |
| 2022 Q1 | $135,498,000 | $496,110,000 | +$22,246 | 365.94% | 8 |
| 2021 Q4 | $135,498,000 | $604,570,000 | +$17,288,255 | 445.81% | 8 |
| 2021 Q3 | $132,393,000 | $467,139,000 | +$68,753,868 | 353.46% | 9 |
| 2021 Q2 | $126,460,257 | $267,540,143 | -$5,340,817 | 207.13% | 13 |
| 2021 Q1 | $127,226,974 | $310,644,774 | -$2,910,939 | 238.25% | 15 |
| 2020 Q4 | $129,286,693 | $279,642,000 | +$25,355,404 | 215.69% | 16 |
| 2020 Q3 | $119,778,931 | $267,200,000 | +$12,476,199 | 222.45% | 15 |
| 2020 Q2 | $113,140,077 | $269,308,670 | -$10,626,790 | 237.52% | 17 |
| 2020 Q1 | $120,618,346 | $160,200,730 | +$160,200,730 | 132.15% | 20 |